InSightec begins clinical trial enrollment

InSightec has initiated enrollment for clinical trials evaluating its ExAblate 2000 MRI-guided focused-ultrasound treatment system in pain palliation of metastatic bone tumors.

Up to 20 patients will be enrolled in the trial, which will be conducted at Charité Hospital in Berlin and St. Mary's Hospital in London, according to InSightec of Tirat Carmel, Israel.

By staff writers
September 15, 2005

Related Reading

GE, Insightec ink new deal, August 17, 2005

GE partners with Insightec, October 25, 2004

InSightec gets $21 million infusion, September 29, 2004

Copyright © 2005

Page 1 of 57
Next Page